Guardian Pharmacy Services, Inc. (NYSE:GRDN) — Stock Price
Guardian Pharmacy Services, Inc. (NYSE:GRDN) is currently trading at $41.47 USD, down 5.38% today. Over the past 52 weeks, shares have ranged between $22.62 and $43.83. This page tracks Guardian Pharmacy Services, Inc.'s live share price on the NYSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Guardian Pharmacy Services, Inc. (GRDN) total market value.
Guardian Pharmacy Services, Inc. (GRDN) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Guardian Pharmacy Services, Inc.'s daily closing share price and trading volume on the NYSE exchange over the past year, giving a clear view of recent price momentum and liquidity.
Guardian Pharmacy Services, Inc. Income Statement — Revenue, Profit & Earnings by Year
Guardian Pharmacy Services, Inc.'s annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | $1.45 Billion | $1.23 Billion | $1.05 Billion | $908.91 Million | $792.07 Million |
| Cost of Revenue | $1.17 Billion | $984.04 Million | $837.88 Million | $723.04 Million | $630.81 Million |
| Gross Profit | $282.04 Million | $244.37 Million | $208.31 Million | $185.87 Million | $161.26 Million |
| Research & Development | — | — | — | — | — |
| SG&A | $220.02 Million | $299.35 Million | $167.36 Million | $-3.38 Million | $13.03 Million |
| Total Operating Expenses | $193.13 Million | $307.29 Million | $167.36 Million | $133.88 Million | $131.12 Million |
| Operating Income | $88.91 Million | $-62.92 Million | $40.95 Million | $51.99 Million | $30.15 Million |
| EBITDA | $111.25 Million | $-43.43 Million | $58.81 Million | $68.15 Million | $46.49 Million |
| EBIT | $88.91 Million | $-63.20 Million | $40.58 Million | $51.59 Million | $29.96 Million |
| Interest Expense | $665.00K | $3.28 Million | $2.86 Million | $1.93 Million | $1.64 Million |
| Income Before Tax | $73.42 Million | $-66.48 Million | $37.72 Million | $49.66 Million | $28.33 Million |
| Income Tax Expense | $24.46 Million | $4.56 Million | — | — | — |
| Net Income | $49.22 Million | $-87.29 Million | $23.90 Million | $35.42 Million | $16.31 Million |
Guardian Pharmacy Services, Inc. Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Guardian Pharmacy Services, Inc.'s financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | $412.66 Million | $320.81 Million | $271.17 Million | $256.11 Million | $235.85 Million |
| Total Current Assets | $221.63 Million | $151.99 Million | $129.60 Million | $120.00 Million | $111.87 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | $101.61 Million | $97.15 Million | $77.26 Million | $67.83 Million | $55.25 Million |
| Inventory | $43.36 Million | $40.55 Million | $36.73 Million | $41.44 Million | $33.09 Million |
| Property, Plant & Equipment | — | — | — | — | — |
| Goodwill | $79.74 Million | $69.30 Million | $56.05 Million | $56.05 Million | $54.63 Million |
| Total Liabilities | $194.73 Million | $170.83 Million | $211.31 Million | $180.18 Million | $182.53 Million |
| Total Current Liabilities | $160.70 Million | $144.12 Million | $138.01 Million | $112.00 Million | $111.54 Million |
| Long-term Debt | — | — | $18.99 Million | $22.97 Million | $26.99 Million |
| Net Debt | $-28.48 Million | $32.67 Million | $68.40 Million | $62.38 Million | $40.03 Million |
| Total Stockholder Equity | $205.76 Million | $142.67 Million | $28.21 Million | $42.73 Million | $23.93 Million |
| Retained Earnings | $66.34 Million | $17.12 Million | — | — | — |
Guardian Pharmacy Services, Inc. Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Guardian Pharmacy Services, Inc. generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | $100.29 Million | $57.96 Million | $70.82 Million | $48.52 Million | $58.50 Million |
| Capital Expenditures | $19.58 Million | $16.37 Million | $14.56 Million | $16.77 Million | $9.28 Million |
| Free Cash Flow | $80.71 Million | $41.59 Million | $56.26 Million | $31.75 Million | $49.22 Million |
| Investing Cash Flow | $-32.26 Million | $-30.41 Million | $-13.44 Million | $-17.90 Million | $-13.15 Million |
| Financing Cash Flow | $-7.07 Million | $-23.64 Million | $-57.23 Million | $-45.03 Million | $-36.79 Million |
| Dividends Paid | $0.00 | $-35.75 Million | $-38.42 Million | $-30.80 Million | $17.36 Million |
| Stock-Based Compensation | $13.85 Million | $131.49 Million | $-6.09 Million | $-3.38 Million | $13.03 Million |
| Depreciation | $22.34 Million | $19.77 Million | $18.23 Million | $16.56 Million | $16.53 Million |
| Change in Cash | $60.96 Million | $3.91 Million | $145.00K | $-14.40 Million | $8.56 Million |
Guardian Pharmacy Services, Inc. Earnings History — EPS Actual vs. Analyst Estimates
Track Guardian Pharmacy Services, Inc.'s quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 18, 2026 | 0.29 | 0.24 | +20.83% |
| Mar 11, 2026 | 0.37 | 0.27 | +38.32% |
| Nov 10, 2025 | 0.25 | 0.24 | +6.38% |
| Aug 11, 2025 | 0.23 | 0.22 | +6.98% |
| Apr 01, 2025 | 0.19 | 0.22 | -13.64% |
| Mar 27, 2025 | 0.24 | 0.22 | +8.23% |
| Nov 12, 2024 | -2.00 | 0.19 | -1152.63% |
| Aug 28, 2024 | 0.25 | 0.00 | — |